Ornella Di Bella
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects.
Journal: Frontiers in immunology
Published: May 12, 2023
Impact of COVID-19 pandemic on outpatient visit volume in cancer patients: Results of COMETA multicenter retrospective observational study.
Journal: Frontiers in public health
Published: October 22, 2022
Immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 16, 2021
Non-adherence to Mediterranean diet and synergy with lifestyle habits in the occurrence of breast cancer: a case-control study in Italy.
Journal: European review for medical and pharmacological sciences
Published: July 21, 2021
Immunogenicity and Safety of COVID-19 Vaccine BNT162b2 for Patients with Solid Cancer: A Large Cohort Prospective Study from a Single Institution.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 01, 2021
Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia.
Journal: Journal of hematology & oncology
Published: May 18, 2021
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution.
Journal: Journal of hematology & oncology
Published: April 17, 2021
ImmunizziAMO: A School-Based Field Trial to Teach New Generations the Importance of Vaccination through Games and to Fight Vaccine Hesitancy in Italy.
Journal: Vaccines
Published: May 17, 2020
Last Updated: 09/26/2026